Ameriprise’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$960K Sell
107,192
-1,640,114
-94% -$14.7M ﹤0.01% 3255
2025
Q1
$13.1M Buy
1,747,306
+26,725
+2% +$200K ﹤0.01% 1576
2024
Q4
$12.9M Sell
1,720,581
-51,920
-3% -$390K ﹤0.01% 1616
2024
Q3
$13.5M Sell
1,772,501
-93,122
-5% -$708K ﹤0.01% 1568
2024
Q2
$11.5M Sell
1,865,623
-469,568
-20% -$2.9M ﹤0.01% 1623
2024
Q1
$11.9M Buy
2,335,191
+1,122,212
+93% +$5.7M ﹤0.01% 1647
2023
Q4
$7.27M Buy
1,212,979
+563,066
+87% +$3.37M ﹤0.01% 2055
2023
Q3
$4.6M Buy
649,913
+6,876
+1% +$48.7K ﹤0.01% 2342
2023
Q2
$4.53M Buy
643,037
+308,648
+92% +$2.17M ﹤0.01% 2420
2023
Q1
$2.79M Sell
334,389
-497,936
-60% -$4.15M ﹤0.01% 2680
2022
Q4
$9.56M Buy
832,325
+313,623
+60% +$3.6M ﹤0.01% 1773
2022
Q3
$6.54M Buy
518,702
+270,419
+109% +$3.41M ﹤0.01% 2027
2022
Q2
$2.63M Buy
248,283
+114,055
+85% +$1.21M ﹤0.01% 2703
2022
Q1
$2.18M Buy
+134,228
New +$2.18M ﹤0.01% 2872
2021
Q3
Sell
-47,483
Closed -$751K 3853
2021
Q2
$751K Sell
47,483
-2,851
-6% -$45.1K ﹤0.01% 3318
2021
Q1
$512K Sell
50,334
-20,240
-29% -$206K ﹤0.01% 3391
2020
Q4
$525K Buy
70,574
+19,950
+39% +$148K ﹤0.01% 3322
2020
Q3
$174K Sell
50,624
-29,342
-37% -$101K ﹤0.01% 3563
2020
Q2
$381K Buy
+79,966
New +$381K ﹤0.01% 3286
2020
Q1
Sell
-109,019
Closed -$377K 3642
2019
Q4
$377K Buy
109,019
+21,769
+25% +$75.3K ﹤0.01% 3422
2019
Q3
$250K Buy
+87,250
New +$250K ﹤0.01% 3491
2019
Q1
Sell
-118,223
Closed -$954K 3676
2018
Q4
$954K Buy
+118,223
New +$954K ﹤0.01% 2954
2014
Q3
Sell
-30
Closed 5755
2014
Q2
$0 Buy
+30
New ﹤0.01% 5560
2013
Q4
Sell
-3,000
Closed -$22K 5131
2013
Q3
$22K Buy
+3,000
New +$22K ﹤0.01% 4342